Phospholipid biosynthesis, Phosphatidylethanolaminen-methyltransferase-lik e
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 7 |
NetGPI | no | yes: 0, no: 7 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005789 | endoplasmic reticulum membrane | 4 | 8 |
GO:0016020 | membrane | 2 | 8 |
GO:0031090 | organelle membrane | 3 | 8 |
GO:0031966 | mitochondrial membrane | 4 | 8 |
GO:0110165 | cellular anatomical entity | 1 | 8 |
Related structures:
AlphaFold database: A4I735
Term | Name | Level | Count |
---|---|---|---|
GO:0006629 | lipid metabolic process | 3 | 8 |
GO:0006644 | phospholipid metabolic process | 4 | 8 |
GO:0006650 | glycerophospholipid metabolic process | 5 | 8 |
GO:0006656 | phosphatidylcholine biosynthetic process | 5 | 8 |
GO:0006793 | phosphorus metabolic process | 3 | 8 |
GO:0006796 | phosphate-containing compound metabolic process | 4 | 8 |
GO:0006807 | nitrogen compound metabolic process | 2 | 8 |
GO:0008152 | metabolic process | 1 | 8 |
GO:0008610 | lipid biosynthetic process | 4 | 8 |
GO:0008654 | phospholipid biosynthetic process | 5 | 8 |
GO:0009058 | biosynthetic process | 2 | 8 |
GO:0009987 | cellular process | 1 | 8 |
GO:0019637 | organophosphate metabolic process | 3 | 8 |
GO:0032259 | methylation | 2 | 8 |
GO:0044237 | cellular metabolic process | 2 | 8 |
GO:0044238 | primary metabolic process | 2 | 8 |
GO:0044249 | cellular biosynthetic process | 3 | 8 |
GO:0044255 | cellular lipid metabolic process | 3 | 8 |
GO:0045017 | glycerolipid biosynthetic process | 4 | 8 |
GO:0046470 | phosphatidylcholine metabolic process | 4 | 8 |
GO:0046474 | glycerophospholipid biosynthetic process | 5 | 8 |
GO:0046486 | glycerolipid metabolic process | 4 | 8 |
GO:0071704 | organic substance metabolic process | 2 | 8 |
GO:0090407 | organophosphate biosynthetic process | 4 | 8 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 8 |
GO:1901566 | organonitrogen compound biosynthetic process | 4 | 8 |
GO:1901576 | organic substance biosynthetic process | 3 | 8 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000773 | phosphatidyl-N-methylethanolamine N-methyltransferase activity | 6 | 8 |
GO:0003824 | catalytic activity | 1 | 8 |
GO:0004608 | phosphatidylethanolamine N-methyltransferase activity | 6 | 8 |
GO:0008168 | methyltransferase activity | 4 | 8 |
GO:0008170 | N-methyltransferase activity | 5 | 8 |
GO:0008757 | S-adenosylmethionine-dependent methyltransferase activity | 5 | 8 |
GO:0016740 | transferase activity | 2 | 8 |
GO:0016741 | transferase activity, transferring one-carbon groups | 3 | 8 |
GO:0080101 | phosphatidyl-N-dimethylethanolamine N-methyltransferase activity | 6 | 8 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 200 | 202 | PF00675 | 0.322 |
CLV_NRD_NRD_1 | 216 | 218 | PF00675 | 0.314 |
CLV_NRD_NRD_1 | 35 | 37 | PF00675 | 0.376 |
CLV_PCSK_KEX2_1 | 202 | 204 | PF00082 | 0.327 |
CLV_PCSK_KEX2_1 | 35 | 37 | PF00082 | 0.413 |
CLV_PCSK_KEX2_1 | 46 | 48 | PF00082 | 0.396 |
CLV_PCSK_PC1ET2_1 | 202 | 204 | PF00082 | 0.327 |
CLV_PCSK_PC1ET2_1 | 46 | 48 | PF00082 | 0.337 |
CLV_PCSK_PC7_1 | 31 | 37 | PF00082 | 0.392 |
DOC_PP4_FxxP_1 | 149 | 152 | PF00568 | 0.488 |
DOC_PP4_FxxP_1 | 191 | 194 | PF00568 | 0.527 |
DOC_USP7_MATH_1 | 2 | 6 | PF00917 | 0.461 |
DOC_USP7_MATH_1 | 210 | 214 | PF00917 | 0.688 |
LIG_14-3-3_CanoR_1 | 140 | 146 | PF00244 | 0.488 |
LIG_EH_1 | 192 | 196 | PF12763 | 0.485 |
LIG_FHA_1 | 110 | 116 | PF00498 | 0.395 |
LIG_FHA_1 | 12 | 18 | PF00498 | 0.331 |
LIG_FHA_1 | 175 | 181 | PF00498 | 0.401 |
LIG_FHA_1 | 194 | 200 | PF00498 | 0.488 |
LIG_FHA_1 | 83 | 89 | PF00498 | 0.451 |
LIG_LIR_Apic_2 | 147 | 152 | PF02991 | 0.488 |
LIG_LIR_Gen_1 | 117 | 124 | PF02991 | 0.401 |
LIG_LIR_Gen_1 | 192 | 200 | PF02991 | 0.508 |
LIG_LIR_Gen_1 | 24 | 34 | PF02991 | 0.401 |
LIG_LIR_LC3C_4 | 112 | 116 | PF02991 | 0.433 |
LIG_LIR_Nem_3 | 117 | 122 | PF02991 | 0.347 |
LIG_LIR_Nem_3 | 131 | 136 | PF02991 | 0.488 |
LIG_LIR_Nem_3 | 24 | 29 | PF02991 | 0.401 |
LIG_Pex14_2 | 191 | 195 | PF04695 | 0.527 |
LIG_PTB_Apo_2 | 148 | 155 | PF02174 | 0.527 |
LIG_PTB_Phospho_1 | 148 | 154 | PF10480 | 0.527 |
LIG_SH2_CRK | 9 | 13 | PF00017 | 0.327 |
LIG_SH2_NCK_1 | 51 | 55 | PF00017 | 0.317 |
LIG_SH2_STAP1 | 51 | 55 | PF00017 | 0.317 |
LIG_SH2_STAT5 | 128 | 131 | PF00017 | 0.488 |
LIG_SH2_STAT5 | 132 | 135 | PF00017 | 0.488 |
LIG_SH2_STAT5 | 154 | 157 | PF00017 | 0.333 |
LIG_SH2_STAT5 | 190 | 193 | PF00017 | 0.488 |
LIG_SH3_3 | 75 | 81 | PF00018 | 0.339 |
LIG_SUMO_SIM_par_1 | 112 | 118 | PF11976 | 0.472 |
LIG_TYR_ITIM | 7 | 12 | PF00017 | 0.379 |
LIG_WRC_WIRS_1 | 116 | 121 | PF05994 | 0.472 |
MOD_CK1_1 | 11 | 17 | PF00069 | 0.258 |
MOD_Cter_Amidation | 44 | 47 | PF01082 | 0.383 |
MOD_GlcNHglycan | 186 | 189 | PF01048 | 0.258 |
MOD_GlcNHglycan | 212 | 215 | PF01048 | 0.469 |
MOD_GlcNHglycan | 60 | 63 | PF01048 | 0.421 |
MOD_GSK3_1 | 110 | 117 | PF00069 | 0.347 |
MOD_NEK2_1 | 107 | 112 | PF00069 | 0.325 |
MOD_NEK2_1 | 114 | 119 | PF00069 | 0.270 |
MOD_NEK2_1 | 122 | 127 | PF00069 | 0.267 |
MOD_NEK2_1 | 155 | 160 | PF00069 | 0.338 |
MOD_NEK2_1 | 162 | 167 | PF00069 | 0.359 |
MOD_PIKK_1 | 82 | 88 | PF00454 | 0.417 |
MOD_PKA_1 | 35 | 41 | PF00069 | 0.567 |
MOD_PKA_2 | 139 | 145 | PF00069 | 0.488 |
MOD_PKA_2 | 35 | 41 | PF00069 | 0.605 |
MOD_Plk_4 | 110 | 116 | PF00069 | 0.347 |
MOD_Plk_4 | 124 | 130 | PF00069 | 0.347 |
MOD_Plk_4 | 171 | 177 | PF00069 | 0.425 |
MOD_Plk_4 | 21 | 27 | PF00069 | 0.401 |
TRG_AP2beta_CARGO_1 | 131 | 140 | PF09066 | 0.488 |
TRG_DiLeu_BaLyEn_6 | 75 | 80 | PF01217 | 0.293 |
TRG_ENDOCYTIC_2 | 132 | 135 | PF00928 | 0.513 |
TRG_ENDOCYTIC_2 | 9 | 12 | PF00928 | 0.381 |
TRG_ER_diArg_1 | 200 | 203 | PF00400 | 0.522 |
TRG_ER_diArg_1 | 34 | 36 | PF00400 | 0.606 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P6H5 | Leptomonas seymouri | 69% | 99% |
A0A0S4IUX3 | Bodo saltans | 51% | 100% |
A0A3Q8IF09 | Leishmania donovani | 98% | 100% |
A4HJL2 | Leishmania braziliensis | 77% | 100% |
C8VRV0 | Emericella nidulans (strain FGSC A4 / ATCC 38163 / CBS 112.46 / NRRL 194 / M139) | 42% | 100% |
E9B230 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 86% | 100% |
O74827 | Schizosaccharomyces pombe (strain 972 / ATCC 24843) | 40% | 99% |
P05375 | Saccharomyces cerevisiae (strain ATCC 204508 / S288c) | 43% | 100% |
Q08388 | Rattus norvegicus | 41% | 100% |
Q4Q632 | Leishmania major | 89% | 100% |
Q54H80 | Dictyostelium discoideum | 29% | 100% |
Q54SD5 | Dictyostelium discoideum | 39% | 100% |
Q61907 | Mus musculus | 40% | 100% |
Q7S5W9 | Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) | 44% | 100% |
Q7YRH6 | Bos taurus | 44% | 100% |
Q9UBM1 | Homo sapiens | 40% | 100% |